SS-31

SS-31 is a synthetic peptide derived from the human protein survivin, a member of the inhibitor of apoptosis protein family. Originally identified for its potent protective effects against oxidative stress, SS-31 has emerged as a subject of significant interest within the scientific community for its potential applications in cellular research and biomarker studies.

Research Context

SS-31 was first synthesized in the early 2000s and has since been extensively studied for its ability to mitigate damage caused by reactive oxygen species (ROS), a class of molecules that play a critical role in cellular aging and degenerative processes. Early research focused on its application in animal models to assess its protective effects against ischemia/reperfusion injury, a condition characterized by tissue damage resulting from disrupted blood flow. Its mechanism of action is believed to involve the stabilization of mitochondrial membranes, enhancement of cellular antioxidant defenses, and modulation of inflammatory pathways.

Research Overview

SS-31 has been utilized in a variety of preclinical studies, including investigations into cardiovascular disease, neurodegenerative disorders, and metabolic dysfunction. Its unique profile has made it a valuable tool for researchers exploring mechanisms underlying oxidative stress, cell survival, and tissue integrity. Notably, SS-31 has demonstrated the ability to improve endothelial function, reduce inflammation, and enhance cardiac recovery in experimental settings. However, ongoing research continues to refine its potential applications and elucidate its full biological impact.

Key Research Focus Areas

• Cardiovascular Health: SS-31 has been studied for its potential role in protecting against myocardial infarction, improving endothelial function, and enhancing recovery from ischemic events.
• Neurodegenerative Diseases: Investigations have examined its neuroprotective effects in models of Alzheimer’s disease, Parkinson’s disease, and traumatic brain injury, focusing on mechanisms of mitochondrial integrity and antioxidant defense.
• Metabolic and Age-Related Disorders: Research includes its impact on metabolic syndrome, diabetes, and aging-related cellular dysfunction, particularly through its modulation of oxidative stress and inflammation.
• Cellular and Molecular Biology: Studies have explored SS-31’s effects on apoptosis regulation, protein expression, and signaling pathways in various cell types, including cardiomyocytes, neurons, and endothelial cells.
• Biomarker Development: The peptide has been evaluated as a potential biomarker for oxidative stress and cellular damage in both animal models and human tissues.

It is important to note that SS-31 is designed for use in controlled experimental settings under the supervision of qualified researchers. Its synthetic nature allows for precise manipulation in research contexts, enabling the investigation of mechanisms that may not be feasible in natural biological systems.

Safety and Compliance

While SS-31 exhibits promising biological activity in preclinical studies, its use in research does not imply approval for therapeutic, diagnostic, or cosmetic applications. Researchers must adhere to strict regulatory guidelines governing the handling and administration of experimental compounds. This product is provided for academic or institutional research purposes only and must be used in accordance with local, national, and international laws and ethical standards.

For research use only. Not for human or animal consumption.